Photograph by Nicolas Guyonnet
Pharmaceutical firms across Asia, Africa and Latin America with potential to manufacture mRNA vaccines
This analysis, published in December 2021, in collaboration with Achal Prabhala, coordinator of the AccessIBSA project, identified more than 100 manufacturers across Asia, Africa and Latin America with the technical requirements and quality standards to manufacture mRNA vaccines.